{"log_id": 1563299326076766472, "direction": 0, "words_result_num": 34, "words_result": [{"probability": {"variance": 0, "average": 0.995382, "min": 0.995382}, "location": {"width": 38, "top": 52, "height": 36, "left": 1486}, "words": "督"}, {"probability": {"variance": 0, "average": 0.998873, "min": 0.998873}, "location": {"width": 61, "top": 107, "height": 38, "left": 1473}, "words": "明"}, {"probability": {"variance": 0.009077, "average": 0.963192, "min": 0.514962}, "location": {"width": 719, "top": 235, "height": 36, "left": 173}, "words": "度增加,如发现过度增加,应给予减量或停药等适当处置"}, {"probability": {"variance": 0.003202, "average": 0.982094, "min": 0.64955}, "location": {"width": 1050, "top": 301, "height": 36, "left": 248}, "words": "[4)虽然本品临床试验未发生过敏反应病例,但国外同类制剂曾发生少数过敏反应(发"}, {"probability": {"variance": 0.018556, "average": 0.91133, "min": 0.403813}, "location": {"width": 1123, "top": 367, "height": 38, "left": 173}, "words": "生率<1/4.00),可表现为皮、荨麻疹、颜面浮肿、呼困难、心动过速及低血压,多在"}, {"probability": {"variance": 0.000995, "average": 0.987794, "min": 0.803973}, "location": {"width": 1121, "top": 436, "height": 36, "left": 175}, "words": "使用本品30分钟内发生,应立即停用,经抗组织胺、皮质激素、支气管解痉剂和(或)肾"}, {"probability": {"variance": 0.011884, "average": 0.965604, "min": 0.481722}, "location": {"width": 1112, "top": 502, "height": 36, "left": 173}, "words": "上腺素等处理后症状能迅速消失,这些病例不应再次使用致敏药物,另外为预测过敏反应等"}, {"probability": {"variance": 0.009925, "average": 0.952741, "min": 0.624673}, "location": {"width": 605, "top": 566, "height": 36, "left": 175}, "words": "使用时应充分问诊、并建议预先用本药物做皮试"}, {"probability": {"variance": 0.006661, "average": 0.96544, "min": 0.672509}, "location": {"width": 1023, "top": 630, "height": 36, "left": 262}, "words": "5)本品给药后可能会引起骨痛、腰痛等,此时可给予非麻醉性锁痛剂等适当处理"}, {"probability": {"variance": 0.00118, "average": 0.988997, "min": 0.811923}, "location": {"width": 973, "top": 698, "height": 34, "left": 324}, "words": "对癌症化疗引起的中性粒细胞减少症思者,在给予癌症化疗药物的前24小时内"}, {"probability": {"variance": 3e-06, "average": 0.998566, "min": 0.993389}, "location": {"width": 504, "top": 765, "height": 34, "left": 173}, "words": "以及给药后的24小时内应避免使用本药"}, {"probability": {"variance": 0.020078, "average": 0.940943, "min": 0.433965}, "location": {"width": 1041, "top": 831, "height": 34, "left": 258}, "words": "7)对于急性髓性白血病患者(化疗和骨髓移时)应用本药前,建议对采集细胞进"}, {"probability": {"variance": 0.001052, "average": 0.985247, "min": 0.845436}, "location": {"width": 1126, "top": 895, "height": 36, "left": 173}, "words": "行体外实验,以确认本药不促进白血病细胞增多。同时,应定期进行血液检查,发现幼稚细"}, {"probability": {"variance": 0.00168, "average": 0.967748, "min": 0.904172}, "location": {"width": 210, "top": 961, "height": 34, "left": 171}, "words": "胞增多时应停药"}, {"probability": {"variance": 0.004028, "average": 0.9795, "min": 0.657149}, "location": {"width": 1039, "top": 1025, "height": 36, "left": 258}, "words": "8)骨髓异常增生综合征中,由干已知伴有幼稚细胞增多的类型有转化为髓性白血病"}, {"probability": {"variance": 0.003351, "average": 0.974108, "min": 0.718553}, "location": {"width": 1112, "top": 1091, "height": 36, "left": 173}, "words": "的危险性,因此应用本药时,建议采集细胞进行体外实验,以证实幼稚细胞集落无增多现象"}, {"probability": {"variance": 0.003665, "average": 0.973241, "min": 0.793507}, "location": {"width": 262, "top": 1158, "height": 34, "left": 232}, "words": "3.应用时的注意事项"}, {"probability": {"variance": 0.002074, "average": 0.976126, "min": 0.777972}, "location": {"width": 870, "top": 1221, "height": 36, "left": 269}, "words": "1)本品为单点式(易断〕安瓿,建议用酒精棉球等消毒断点后取用"}, {"probability": {"variance": 0.001803, "average": 0.981392, "min": 0.77006}, "location": {"width": 931, "top": 1288, "height": 36, "left": 255}, "words": "(2)静脉点滴时,与5%葡萄糖溶液或生理盐水混合后注射,勿与其他药"}, {"probability": {"variance": 0.000321, "average": 0.985029, "min": 0.959768}, "location": {"width": 93, "top": 1354, "height": 34, "left": 173}, "words": "物混用"}, {"probability": {"variance": 0.000686, "average": 0.986593, "min": 0.891014}, "location": {"width": 488, "top": 1418, "height": 34, "left": 255}, "words": "(3)静脉内给药时,速度应尽量缓慢"}, {"probability": {"variance": 0.001443, "average": 0.984033, "min": 0.8837}, "location": {"width": 207, "top": 1482, "height": 34, "left": 239}, "words": "4.其他注意事项"}, {"probability": {"variance": 0.000449, "average": 0.989698, "min": 0.900377}, "location": {"width": 922, "top": 1548, "height": 34, "left": 271}, "words": "1)有报告指出,再生障碍性贫血及先天性中性粒细胞减少症患者,应用"}, {"probability": {"variance": 0.011871, "average": 0.955766, "min": 0.404943}, "location": {"width": 1112, "top": 1605, "height": 137, "left": 171}, "words": "粒细胞刺因子后,有转为骨髓异常增生综合征或急性髓性白血病的例 NE ENGINEER"}, {"probability": {"variance": 0.004337, "average": 0.975296, "min": 0.63769}, "location": {"width": 922, "top": 1678, "height": 36, "left": 271}, "words": "2)有报告指出给再生障碍性贫血、骨髓异常增生综合征及先天性中性粒"}, {"probability": {"variance": 0.00062, "average": 0.97278, "min": 0.947879}, "location": {"width": 111, "top": 1706, "height": 41, "left": 1080}, "words": "杭州"}, {"probability": {"variance": 0.002262, "average": 0.981769, "min": 0.791835}, "location": {"width": 888, "top": 1742, "height": 36, "left": 175}, "words": "细胞减少症的患者应用粒细胞刺激因子后,有的病例发生了染色体异常"}, {"probability": {"variance": 3.5e-05, "average": 0.995795, "min": 0.983996}, "location": {"width": 189, "top": 1761, "height": 43, "left": 1050}, "words": "源基因工程"}, {"probability": {"variance": 0.016782, "average": 0.953071, "min": 0.365635}, "location": {"width": 1005, "top": 1799, "height": 68, "left": 271}, "words": "3)有报告指出粒细胞刺激因子在体外或体内实验中,对多种膀公司"}, {"probability": {"variance": 0.021818, "average": 0.95619, "min": 0.385184}, "location": {"width": 493, "top": 1872, "height": 34, "left": 173}, "words": "癌及骨肉瘤细胞具有促进增殖的向"}, {"probability": {"variance": 0.00012, "average": 0.993124, "min": 0.961706}, "location": {"width": 312, "top": 1939, "height": 34, "left": 173}, "words": "[孕妇及哺乳期妇女用药"}, {"probability": {"variance": 0.037101, "average": 0.894092, "min": 0.358206}, "location": {"width": 813, "top": 2000, "height": 36, "left": 237}, "words": "不用干妊娠或可能怀孕的女虹娠中的几药安全性尚未确定〕"}, {"probability": {"variance": 0.001274, "average": 0.976055, "min": 0.906901}, "location": {"width": 141, "top": 2064, "height": 38, "left": 185}, "words": "儿童用药]"}, {"probability": {"variance": 0.015043, "average": 0.931116, "min": 0.463381}, "location": {"width": 1041, "top": 2131, "height": 36, "left": 242}, "words": "1.对早产儿、新生儿及婴幼儿用药的安全性尚末确定,建议不用该药(使用经验较少)"}], "language": 3}